JP2001513080A5 - - Google Patents

Download PDF

Info

Publication number
JP2001513080A5
JP2001513080A5 JP1998535034A JP53503498A JP2001513080A5 JP 2001513080 A5 JP2001513080 A5 JP 2001513080A5 JP 1998535034 A JP1998535034 A JP 1998535034A JP 53503498 A JP53503498 A JP 53503498A JP 2001513080 A5 JP2001513080 A5 JP 2001513080A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP1998535034A
Other languages
English (en)
Japanese (ja)
Other versions
JP2001513080A (ja
JP4975201B2 (ja
Filing date
Publication date
Priority claimed from US08/796,339 external-priority patent/US5804688A/en
Priority claimed from US08/796,335 external-priority patent/US5876710A/en
Priority claimed from US08/796,336 external-priority patent/US6358504B1/en
Priority claimed from US08/797,820 external-priority patent/US5990166A/en
Priority claimed from US08/796,340 external-priority patent/US5939381A/en
Priority claimed from US08/797,816 external-priority patent/US6090958A/en
Priority claimed from US08/796,334 external-priority patent/US5879681A/en
Priority claimed from US08/796,337 external-priority patent/US5773647A/en
Priority claimed from US08/797,813 external-priority patent/US6051561A/en
Priority claimed from US08/797,817 external-priority patent/US6060513A/en
Priority claimed from US08/796,338 external-priority patent/US5776888A/en
Priority claimed from US08/797,100 external-priority patent/US6313088B1/en
Application filed filed Critical
Priority claimed from PCT/US1998/002619 external-priority patent/WO1998034632A1/en
Publication of JP2001513080A publication Critical patent/JP2001513080A/ja
Publication of JP2001513080A5 publication Critical patent/JP2001513080A5/ja
Application granted granted Critical
Publication of JP4975201B2 publication Critical patent/JP4975201B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP53503498A 1997-02-07 1998-02-06 化合物及び活性剤を送達するための組成物 Expired - Fee Related JP4975201B2 (ja)

Applications Claiming Priority (27)

Application Number Priority Date Filing Date Title
US79634197A 1997-02-07 1997-02-07
US08/797,816 US6090958A (en) 1995-03-31 1997-02-07 Compounds and compositions for delivering active agents
US08/796,334 US5879681A (en) 1997-02-07 1997-02-07 Compounds and compositions for delivering active agents
US08/796,338 1997-02-07
US08/797,817 1997-02-07
US08/796,337 US5773647A (en) 1997-02-07 1997-02-07 Compounds and compositions for delivering active agents
US08/797,817 US6060513A (en) 1997-02-07 1997-02-07 Compounds and compositions for delivering active agents
US08/796,334 1997-02-07
US08/796,341 1997-02-07
US08/796,340 1997-02-07
US08/797,820 1997-02-07
US08/797,813 US6051561A (en) 1997-02-07 1997-02-07 Compounds and compositions for delivering active agents
US08/797,816 1997-02-07
US08/796,336 1997-02-07
US08/796,335 1997-02-07
US08/796,339 1997-02-07
US08/797,813 1997-02-07
US08/796,337 1997-02-07
US08/797,100 1997-02-07
US08/796,339 US5804688A (en) 1997-02-07 1997-02-07 Compounds and compositions for delivering active agents
US08/797,100 US6313088B1 (en) 1997-02-07 1997-02-07 8-[(2-hydroxy-4-methoxy benzoyl) amino]-octanoic acid compositions for delivering active agents
US08/796,338 US5776888A (en) 1997-02-07 1997-02-07 Compounds and compositions for delivering active agents
US08/796,335 US5876710A (en) 1997-02-07 1997-02-07 Compounds and compositions for delivering active agents
US08/796,340 US5939381A (en) 1997-02-07 1997-02-07 Compounds and compositions for delivering active agents
US08/797,820 US5990166A (en) 1997-02-07 1997-02-07 Compounds and compositions for delivering active agents
US08/796,336 US6358504B1 (en) 1997-02-07 1997-02-07 Compounds and compositions for delivering active agents
PCT/US1998/002619 WO1998034632A1 (en) 1997-02-07 1998-02-06 Compounds and compositions for delivering active agents

Related Child Applications (3)

Application Number Title Priority Date Filing Date
JP2000311231A Division JP3964613B2 (ja) 1997-02-07 2000-10-11 化合物及び活性剤を送達するための組成物
JP2000311230A Division JP4012679B2 (ja) 1997-02-07 2000-10-11 化合物及び活性剤を送達するための組成物
JP2009246865A Division JP5215977B2 (ja) 1997-02-07 2009-10-27 化合物及び活性剤を送達するための組成物

Publications (3)

Publication Number Publication Date
JP2001513080A JP2001513080A (ja) 2001-08-28
JP2001513080A5 true JP2001513080A5 (https=) 2007-06-07
JP4975201B2 JP4975201B2 (ja) 2012-07-11

Family

ID=27584608

Family Applications (3)

Application Number Title Priority Date Filing Date
JP53503498A Expired - Fee Related JP4975201B2 (ja) 1997-02-07 1998-02-06 化合物及び活性剤を送達するための組成物
JP2000311230A Expired - Fee Related JP4012679B2 (ja) 1997-02-07 2000-10-11 化合物及び活性剤を送達するための組成物
JP2000311231A Expired - Fee Related JP3964613B2 (ja) 1997-02-07 2000-10-11 化合物及び活性剤を送達するための組成物

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2000311230A Expired - Fee Related JP4012679B2 (ja) 1997-02-07 2000-10-11 化合物及び活性剤を送達するための組成物
JP2000311231A Expired - Fee Related JP3964613B2 (ja) 1997-02-07 2000-10-11 化合物及び活性剤を送達するための組成物

Country Status (9)

Country Link
EP (3) EP0993831B1 (https=)
JP (3) JP4975201B2 (https=)
AT (2) ATE383169T1 (https=)
CA (3) CA2319680C (https=)
DK (2) DK1093819T3 (https=)
ES (2) ES2297909T3 (https=)
NZ (3) NZ337131A (https=)
PT (1) PT1093819E (https=)
WO (1) WO1998034632A1 (https=)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI9720025A (sl) 1996-03-29 1999-08-31 Emishphere Technologies, Inc. Spojine in sestavki za prenos aktivne snovi
EP0930883B1 (en) 1996-10-21 2006-01-11 Allelix Biopharmaceuticals Inc. Neurotrophin antagonists for the treatment of epilepsy, alzheimer's disease and pain
US6358504B1 (en) 1997-02-07 2002-03-19 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
CN1313439C (zh) 1998-08-07 2007-05-02 艾米斯菲尔技术有限公司 用于送递活性剂的化合物和组合物
EP1676832A3 (en) * 1998-08-07 2006-09-06 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
CA2361716C (en) 1999-02-05 2009-04-28 Emisphere Technologies, Inc. Method of preparing alkylated salicylamides
EP1175390B1 (en) * 1999-04-05 2005-02-02 Emisphere Technologies, Inc. Disodium salts, monohydrates, and ethanol solvates
US6492380B1 (en) 1999-05-17 2002-12-10 Queen's University At Kingston Method of inhibiting neurotrophin-receptor binding
US6468990B1 (en) 1999-05-17 2002-10-22 Queen's University At Kingston Method of inhibiting binding of nerve growth factor to p75 NTR receptor
KR20020070285A (ko) 1999-11-23 2002-09-05 메틸진, 인크. 히스톤 디아세틸라제의 억제제
JP4879433B2 (ja) 2000-01-13 2012-02-22 エミスフェアー・テクノロジーズ・インク 活性剤を送達するための化合物および組成物
ES2386263T3 (es) * 2000-03-21 2012-08-14 Emisphere Technologies, Inc. Método de preparación de salicilamidas alquiladas mediante un producto intermedio de dicarboxilato
WO2001083427A1 (en) * 2000-04-28 2001-11-08 Sankyo Company, Limited PPARη MODULATORS
US7227033B2 (en) * 2002-01-09 2007-06-05 Emisphere Technologies, Inc. Polymorphs of sodium 4-[(4-chloro-2-hydroxybenzoyl) amino] butanoate
JP2004521857A (ja) * 2000-06-29 2004-07-22 エミスフェアー・テクノロジーズ・インク 活性剤の送達のための化合物及び組成物
JP4707931B2 (ja) 2000-08-18 2011-06-22 エミスフェアー・テクノロジーズ・インク 活性剤デリバリー用化合物および組成物
US7049283B2 (en) 2000-12-06 2006-05-23 Novartis Ag Pharmaceutical compositions for the oral delivery of pharmacologically active agents
PL211976B1 (pl) 2001-06-01 2012-07-31 Novartis Ag Kompozycja farmaceutyczna do podawania doustnego oraz zastosowanie kompozycji
SE0102764D0 (sv) 2001-08-17 2001-08-17 Astrazeneca Ab Compounds
EP1420827B8 (en) * 2001-08-17 2009-12-23 Novartis AG 5-cnac as oral delivery agent for parathyroid hormone fragments
WO2003035602A1 (en) * 2001-10-25 2003-05-01 Sankyo Company, Limited Lipid modulators
AU2002352974A1 (en) 2001-11-29 2003-06-10 Emisphere Technologies, Inc. Formulations for oral administration of cromolyn sodium
CN1332711C (zh) * 2002-02-20 2007-08-22 埃米球科技有限公司 施用glp－1分子的方法
TW200403052A (en) * 2002-07-17 2004-03-01 Novartis Ag Use of organic compounds
CN1506359A (zh) * 2002-12-05 2004-06-23 �й�ҽѧ��ѧԺҩ���о��� 新的香豆素酰胺衍生物及其制法和其药物组合物与用途
BRPI0411165A (pt) * 2003-05-14 2006-07-11 Emisphere Tech Inc composição farmacêutica, forma de unidade de dosagem e métodos para preparar seu uso
BRPI0411114B8 (pt) * 2003-06-10 2021-05-25 Lg Chemical Ltd solução aquosa estável de eritropoetina humana, não contendo albumina de soro
CA2532026C (en) * 2003-08-20 2012-04-17 Eli Lilly And Company Compounds, methods and formulations for the oral delivery of a glucagon like peptide (glp)-1 compound or an melanocortin 4 receptor (mc4) agonist peptide
ATE361294T1 (de) * 2003-08-20 2007-05-15 Lilly Co Eli Verbindungen, verfahren und formulierungen zur oralen verabreichung einer glucagonartigen peptid (glp)-1-verbindung oder eines melanocortin-4- rezeptor-(mc4-)agonistschen peptids
NZ551196A (en) * 2004-05-14 2010-08-27 Emisphere Tech Inc Compounds and compositions for delivering active agents
CN1968704B (zh) * 2004-05-19 2010-12-08 爱密斯菲尔科技公司 局部用色甘酸制剂
AU2005244985B2 (en) 2004-05-19 2011-09-01 Emisphere Technologies, Inc. Acyclovir formulations
US9399054B2 (en) * 2004-07-12 2016-07-26 Emisphere Technologies, Inc. Compositions for delivering peptide YY and PYY agonists
CN101014360A (zh) 2004-08-03 2007-08-08 埃米斯菲尔技术公司 抗糖尿病口服胰岛素－双胍组合物
WO2006124047A2 (en) * 2004-08-13 2006-11-23 Emisphere Technologies, Inc. Pharmaceutical formulations containing microparticles or nanoparticles of a delivery agent
WO2006072070A2 (en) 2004-12-29 2006-07-06 Emisphere Technologies, Inc. Pharmaceutical formulations of gallium salts
WO2006076692A1 (en) 2005-01-12 2006-07-20 Emisphere Technologies, Inc. Compositions for buccal delivery of parathyroid hormone
CA2614746C (en) 2005-07-09 2011-05-10 Astrazeneca Ab Heteroaryl benzamide derivatives for use as glk activators in the treatment of diabetes
WO2007011958A2 (en) 2005-07-15 2007-01-25 Emisphere Technologies, Inc. Intraoral dosage forms of glucagon
WO2007121318A2 (en) 2006-04-12 2007-10-25 Emisphere Technologies, Inc. Formulations for delivering insulin
US8771712B2 (en) 2006-05-09 2014-07-08 Emisphere Technologies, Inc. Topical administration of acyclovir
JP5475443B2 (ja) 2006-06-28 2014-04-16 エミスフェアー・テクノロジーズ・インク 硝酸ガリウム製剤
AU2007289344B2 (en) 2006-08-31 2011-04-14 Novartis Ag Pharmaceutical compositions comprising hGH for oral delivery
CA2662853C (en) 2006-08-31 2016-07-26 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
CN105233294A (zh) 2007-02-08 2016-01-13 爱密斯菲尔科技公司 苯烷基羧酸输送剂
EP2461803B1 (en) * 2009-08-03 2018-10-17 Emisphere Technologies, Inc. Fast-acting naproxen composition with reduced gastrointestinal effects
BR112012020185A2 (pt) * 2010-02-04 2017-07-04 Lowell Parsons C uso de preparações de heparina oral para tratar doenças e afecções do trato urinário.
CN104758936A (zh) * 2015-03-11 2015-07-08 苏州维泰生物技术有限公司 能输送生物活性物质的合成小分子化合物及其应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2517229A1 (de) * 1975-04-18 1976-10-28 Boehringer Mannheim Gmbh Phenylalkylcarbonsaeure-derivate und verfahren zu ihrer herstellung
FR2374910A1 (fr) 1976-10-23 1978-07-21 Choay Sa Preparation a base d'heparine, comprenant des liposomes, procede pour l'obtenir et medicaments contenant de telles preparations
US4757066A (en) * 1984-10-15 1988-07-12 Sankyo Company Limited Composition containing a penem or carbapenem antibiotic and the use of the same
EP0545913B1 (en) 1986-08-18 1999-02-24 Emisphere Technologies, Inc. Delivery systems for pharmacological agents
US5541155A (en) * 1994-04-22 1996-07-30 Emisphere Technologies, Inc. Acids and acid salts and their use in delivery systems
JPH05239021A (ja) 1990-09-04 1993-09-17 Microbial Chem Res Found 新規なアクチノニン誘導体
HU211995B (en) * 1992-06-30 1996-01-29 Gyogyszerkutato Intezet Process to prepare novel benzoyl amino acid derivs. and pharmaceutical compns. contg.them
US5643957A (en) * 1993-04-22 1997-07-01 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
US5650386A (en) 1995-03-31 1997-07-22 Emisphere Technologies, Inc. Compositions for oral delivery of active agents
SI9720025A (sl) * 1996-03-29 1999-08-31 Emishphere Technologies, Inc. Spojine in sestavki za prenos aktivne snovi

Similar Documents

Publication Publication Date Title
JP2000509942A5 (https=)
JP2000510751A5 (https=)
JP2000507042A5 (https=)
JP2000509635A5 (https=)
JP2000509912A5 (https=)
JP2000509637A5 (https=)
JP2000509587A5 (https=)
JP2002514268A5 (https=)
JP2000507369A5 (https=)
JP2000507433A5 (https=)
JP2000508866A5 (https=)
JP2000510793A5 (https=)
JP2000508022A5 (https=)
JP2000508841A5 (https=)
JP2000508680A5 (https=)
JP2000509804A5 (https=)
JP2000509853A5 (https=)
JP2000509755A5 (https=)
JP2000510247A5 (https=)
JP2000510969A5 (https=)
JP2000508836A5 (https=)
JP2000508102A5 (https=)
JP2000509818A5 (https=)
JP2000509520A5 (https=)
JP2000507434A5 (https=)